Cargando…
Acceleration of Translational Mesenchymal Stromal Cell Therapy Through Consistent Quality GMP Manufacturing
Human mesenchymal stromal cell (hMSC) therapy has been gaining immense interest in regenerative medicine and quite recently for its immunomodulatory properties in COVID-19 treatment. Currently, the use of hMSCs for various diseases is being investigated in >900 clinical trials. Despite the huge e...
Autores principales: | Jayaraman, Premkumar, Lim, Ryan, Ng, Jacqueline, Vemuri, Mohan C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076909/ https://www.ncbi.nlm.nih.gov/pubmed/33928083 http://dx.doi.org/10.3389/fcell.2021.648472 |
Ejemplares similares
-
Clinical Translation of Mesenchymal Stromal Cell Therapy for Graft Versus Host Disease
por: Godoy, Juliana A. P., et al.
Publicado: (2019) -
Translational Animal Models Provide Insight Into Mesenchymal Stromal Cell (MSC) Secretome Therapy
por: Harman, Rebecca M., et al.
Publicado: (2021) -
Editorial: Mesenchymal Stromal Cells: Preclinical and Clinical Challenges
por: Oliva, Joan, et al.
Publicado: (2022) -
Quality assessment of a serum and xenofree medium for the expansion of human GMP-grade mesenchymal stromal cells
por: Aussel, Clotilde, et al.
Publicado: (2022) -
Consistent Long-Term Therapeutic Efficacy of Human Umbilical Cord Matrix-Derived Mesenchymal Stromal Cells After Myocardial Infarction Despite Individual Differences and Transient Engraftment
por: Laundos, Tiago L., et al.
Publicado: (2021)